ADAR1 Capital Management, LLC

Track

Insider profile

Performance

Overall performance
3.9
Performance over holding periods
3.9
30 days 90 days 120 days
Average return 27% 8.2% 15.1%
Success rate 95% 68% 82%
Transactions
25 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
ADAR1 Capital Management, LLC's trades of InMed Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-17 2026-07-15
B Purchase
11,865 -21.1%
230.36
US$2,773,536 		11,865 -21.1% 230.36 US$2,773,536
2026-05-21 2026-05-19
B Purchase
42,821 -2.9%
395.95
US$2,986,023 		42,821 -2.9% 395.95 US$2,986,023
2026-05-21 2026-05-19
B Purchase
88,698 +41.7%
73.23
US$3,855,116 		88,698 +41.7% 73.23 US$3,855,116
2026-05-21 2026-05-19
B Purchase
68,551 +20.7%
1.60
US$109,668 		68,551 +20.7% 1.60 US$109,668
2026-05-20 2026-05-19
US Rallybio Corp (RLYB)
B Purchase
200 +0.0%
13.80
US$2,760 		200 +0.0% 13.80 US$2,760
2026-05-20 2026-05-19
US Rallybio Corp (RLYB)
B Purchase
10,000 +1.1%
13.98
US$139,822 		10,000 +1.1% 13.98 US$139,822
2026-05-20 2026-05-18
US Rallybio Corp (RLYB)
B Purchase
6,009 +0.7%
13.98
US$83,981 		6,009 +0.7% 13.98 US$83,981
2026-05-15 2026-05-15
US Rallybio Corp (RLYB)
B Purchase
200 +0.0%
13.95
US$2,790 		200 +0.0% 13.95 US$2,790
2026-05-15 2026-05-15
US Rallybio Corp (RLYB)
B Purchase
100 +0.0%
13.80
US$1,380 		100 +0.0% 13.80 US$1,380
2026-05-15 2026-05-13
US Rallybio Corp (RLYB)
B Purchase
75,178 +9.0%
14.00
US$1,052,492 		75,178 +9.0% 14.00 US$1,052,492
2026-05-15 2026-05-13
US Rallybio Corp (RLYB)
B Purchase
4,081 +0.5%
13.80
US$56,315 		4,081 +0.5% 13.80 US$56,315
2026-05-13 2026-05-12
US Rallybio Corp (RLYB)
B Purchase
800 +0.1%
13.83
US$11,063 		800 +0.1% 13.83 US$11,063
2026-05-13 2026-05-11
US Rallybio Corp (RLYB)
B Purchase
19,900 +2.5%
14.00
US$278,600 		19,900 +2.5% 14.00 US$278,600
2026-05-13 2026-05-11
US Rallybio Corp (RLYB)
B Purchase
25,000 +3.2%
14.00
US$350,000 		25,000 +3.2% 14.00 US$350,000
2026-05-13 2026-05-11
US Rallybio Corp (RLYB)
B Purchase
5,100 +0.7%
14.00
US$71,392 		5,100 +0.7% 14.00 US$71,392
2026-05-06 2026-05-05
US Rallybio Corp (RLYB)
B Purchase
35,101 +4.7%
14.00
US$491,260 		35,101 +4.7% 14.00 US$491,260
2026-05-06 2026-05-04
US Rallybio Corp (RLYB)
B Purchase
116,904 +18.6%
13.97
US$1,633,207 		116,904 +18.6% 13.97 US$1,633,207
2026-05-06 2026-05-04
US Rallybio Corp (RLYB)
B Purchase
3,900 +0.6%
13.90
US$54,201 		3,900 +0.6% 13.90 US$54,201
2025-10-15 2025-10-15
S Sale
743,358 -100.0%
17.75
US$13,194,604 		743,358 -100.0% 17.75 US$13,194,604
2025-10-15 2025-10-15
S Sale
254,669 -100.0%
17.75
US$4,520,375 		254,669 -100.0% 17.75 US$4,520,375
2025-10-15 2025-10-15
S Sale
4,391,237 -100.0%
17.75
US$77,944,457 		4,391,237 -100.0% 17.75 US$77,944,457
2025-04-11 2025-04-09
B Purchase
74,333 +1.7%
10.33
US$767,860 		74,333 +1.7% 10.33 US$767,860
2025-04-11 2025-04-09
B Purchase
500,000 +13.1%
10.33
US$5,165,000 		500,000 +13.1% 10.33 US$5,165,000
2025-04-11 2025-04-09
B Purchase
325,000 +9.3%
9.86
US$3,203,525 		325,000 +9.3% 9.86 US$3,203,525
2025-04-11 2025-04-09
B Purchase
16,365 +2.3%
9.40
US$153,752 		16,365 +2.3% 9.40 US$153,752
2025-04-11 2025-04-09
B Purchase
18,560 +0.5%
9.40
US$174,375 		18,560 +0.5% 9.40 US$174,375
2024-08-12 2024-08-12
B Purchase
757 +5.3%
15.88
US$12,023 		757 +5.3% 15.88 US$12,023
2024-08-12 2024-08-12
B Purchase
2,243 +1.8%
15.88
US$35,624 		2,243 +1.8% 15.88 US$35,624
2024-08-12 2024-08-09
B Purchase
3,000 +2.4%
14.89
US$44,679 		3,000 +2.4% 14.89 US$44,679